In vitro activity of L-627, a new carbapenem.
The in vitro activity of L-627, a new parenterally administered carbapenem, was compared with those of imipenem, meropenem, FCE 22101 (a penem), ceftazidime, and ceftriaxone. L-627 was active against members of the family Enterobacteriaceae (MIC for 90% of strains tested [MIC90] ranging from 0.03 to...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1992
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC192211/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1416883/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.9.1928 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
